drugset / Trial / NCT06821750
A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults
RandomizedSequentialTriple-blindOther
Summary
The purpose of this clinical trial is to learn if the study medicine (called PF-07314470) is safe and how it gets in and out of the body in healthy people.
Timeline
- Start
- 2025-02-11
- Primary completion
- 2025-08-18
- Completion
- 2025-08-18
Outcome
Outcome not reported
Stopped (Business): “The Sponsor has decided to terminate the above referenced clinical study for business reasons. There were no safety concerns that led to this decision and there was no impact to participant safety.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-07314470 | Unknown | — | Subcutaneous |
Indications
No indication recorded.